Regulation of the β‑catenin/LEF‑1 pathway by the siRNA knockdown of RUVBL1 expression inhibits breast cancer cell proliferation, migration and invasion
Oncology Reports · 2024
DOI: 10.3892/or.2024.8855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Xin Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China. Hauptthemen laut MEDLINE: Cell Proliferation, Breast Neoplasms, Cell Movement, ATPases Associated with Diverse Cellular Activities. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China.
- Department of Ultrasound, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China.
Zitieren
APA
Zhang, X., Cui, D., Sun, W., Yang, G., Wang, W., & Mi, C. (2024). Regulation of the β‑catenin/LEF‑1 pathway by the siRNA knockdown of RUVBL1 expression inhibits breast cancer cell proliferation, migration and invasion. Oncology Reports. https://doi.org/10.3892/or.2024.8855
Vancouver
Zhang X, Cui D, Sun W, Yang G, Wang W, Mi C. Regulation of the β‑catenin/LEF‑1 pathway by the siRNA knockdown of RUVBL1 expression inhibits breast cancer cell proliferation, migration and invasion. Oncology Reports. 2024. doi:10.3892/or.2024.8855
BibTeX
@article{Zhang2024,
author = {Zhang, Xin and Cui, Dingyuan and Sun, Wei and Yang, Guangfei and Wang, Wen and Mi, Chengrong},
title = {Regulation of the β‑catenin/LEF‑1 pathway by the siRNA knockdown of RUVBL1 expression inhibits breast cancer cell proliferation, migration and invasion},
journal = {Oncology Reports},
year = {2024},
doi = {10.3892/or.2024.8855}
}
EUVIMED